Lexicon Pharmaceuticals market cap LXRX

Share price times shares outstanding: what the whole company sells for, since 2011.

Lexicon Pharmaceuticals is worth $631.8M at the close on Oct 23, 2026, at $1.42 a share.

That is up 22% over the last year and down 17% over five years.

Its highest close in our data was $2B in Oct 2016.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$631.8M	$414.3M	$1.1B	+41%
2025	$447M	$131.3M	$541.5M	+60%
2024	$279.6M	$254.9M	$778.9M	−25%
2023	$374.7M	$247.4M	$658.7M	+4%
2022	$360.5M	$218.4M	$582.1M	−39%
2021	$586.6M	$451.1M	$999.7M	+46%
2020	$401.8M	$118.9M	$429.3M	−11%
2019	$452.7M	$127.5M	$798.7M	−32%
2018	$666.3M	$666.3M	$1.4B	−36%
2017	$1B	$1B	$1.9B	−27%
2016	$1.4B	$904.6M	$2B	+4%
2015	$1.4B	$458.2M	$1.5B	+194%
2014	$468.5M	$437.6M	$1B	−50%
2013	$934.6M	$903.8M	$1.5B	−4%
2012	$978.6M	$405.2M	$1.4B	+125%
2011	$435.6M	$310.7M	$459.2M	n/a

Companies in Drug Manufacturers - General nearest Lexicon Pharmaceuticals' size, closest first, today.

Company	Market cap
LXRXLexicon Pharmaceuticals	$631.8M
CRMDCorMedix	$611.9M
ZVRAZevra Therapeutics	$582.6M
IRWDIronwood Pharmaceuticals	$571.7M
PBYIPuma Biotechnology	$568.9M
COLLCollegium Pharmaceutical	$747.5M
ABUSArbutus Biopharma	$831M
ARVNArvinas	$477.3M
AMPHAmphastar Pharmaceuticals	$1.1B
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
Peer median	$679.7M